These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 34712772)

  • 21. Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure.
    Galea R; De Marco F; Aminian A; Meneveau N; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Angelillis M; Brugger N; Spirito A; Corpataux N; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Windecker S; Räber L; Valgimigli M
    J Cardiovasc Transl Res; 2021 Oct; 14(5):930-940. PubMed ID: 33884564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First results of the Brazilian Registry of Percutaneous Left Atrial Appendage Closure.
    Guérios ÊE; Chamié F; Montenegro M; Saad EB; Brito FS; Caramori PA; Simões LC; Oliveira FRA; Giuliano LC; Tavares CMDF
    Arq Bras Cardiol; 2017 Nov; 109(5):440-447. PubMed ID: 29069203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pericardial Effusion After Left Atrial Appendage Closure: Timing, Predictors, and Clinical Impact.
    Galea R; Bini T; Krsnik JP; Touray M; Temperli FG; Kassar M; Papadis A; Gloeckler S; Brugger N; Madhkour R; Seiffge DJ; Roten L; Siontis GCM; Heg D; Windecker S; Räber L
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1295-1307. PubMed ID: 38795087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure.
    Saw J; Fahmy P; DeJong P; Lempereur M; Spencer R; Tsang M; Gin K; Jue J; Mayo J; McLaughlin P; Nicolaou S
    Eur Heart J Cardiovasc Imaging; 2015 Nov; 16(11):1198-206. PubMed ID: 25851318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Watchman vs. Amulet for Left Atrial Appendage Closure: Current Evidence and Future Perspectives.
    Frazzetto M; Sanfilippo C; Costa G; Contrafatto C; Giacalone C; Scandura S; Castania G; De Santis J; Sanfilippo M; Di Salvo ME; Tamburino C; Barbanti M; Grasso C
    J Clin Med; 2024 Aug; 13(16):. PubMed ID: 39200792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE).
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Gambhir A; Hermiller J; Nielsen-Kudsk JE; Worthley S; Nair D; Schmidt B; Horton R; Gupta N; Anderson JA; Gage R; Alkhouli M; Windecker S
    JACC Cardiovasc Interv; 2023 Aug; 16(15):1902-1913. PubMed ID: 37587599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amulet device implantation following incomplete left atrial appendage closure with Watchman legacy device.
    Yoon SH; Elgendy AY; Dallan LAP; Filby SJ
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):226-229. PubMed ID: 37870093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term safety and efficacy of left atrial appendage closure in patients with small appendage orifices measured with transesophageal echocardiography.
    Wang B; Wang Z; Chu H; He B; Fu G; Feng M; Du X; Liu J; Yu Y
    Clin Cardiol; 2023 Feb; 46(2):134-141. PubMed ID: 36378742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes of Watchman vs. Amplatzer occluders for left atrial appendage closure (WATCH at LAAC).
    Kleinecke C; Yu J; Neef P; Buffle E; de Marchi S; Fuerholz M; Nietlispach F; Valgimigli M; Streit SR; Fankhauser M; Duenninger E; Windecker S; Meier B; Gloekler S
    Europace; 2020 Jun; 22(6):916-923. PubMed ID: 32003774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center.
    Bai Y; Xue X; Duenninger E; Muenzel M; Jiang L; Keil T; Fazakas A; Yu J
    Heart Vessels; 2019 Aug; 34(8):1360-1369. PubMed ID: 30820642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracardiac vs transesophageal echocardiography for percutaneous left atrial appendage occlusion: A meta-analysis.
    Velagapudi P; Turagam MK; Kolte D; Khera S; Gupta T; Garg J; Abbott JD; George I; Khalique O; Vahl T; Nazif T; Lakkireddy D; Kodali S; Sommer R
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):461-467. PubMed ID: 30585678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation.
    Chen YY; Zhang YH; Chen X; Huang WP; Xu B; Su X; Chen YH
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1831-1839. PubMed ID: 31321654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: current status and future perspectives.
    Wintgens LIS; Maarse M; Swaans MJ; Rensing BJWM; Van Dijk VF; Boersma LVA
    Expert Rev Med Devices; 2020 Jul; 17(7):615-626. PubMed ID: 32543911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort.
    Schrag M; Mac Grory B; Nackenoff A; Eaton J; Mistry E; Kirshner H; Yaghi S; Ellis CR
    Transl Stroke Res; 2021 Apr; 12(2):259-265. PubMed ID: 32770310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet.
    Kleinecke C; Park JW; Gödde M; Zintl K; Schnupp S; Brachmann J
    Cardiol J; 2017; 24(2):131-138. PubMed ID: 28198520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devices.
    Ke JY; Jin LS; Lin YN; Xu J; Liu WK; Fu JY; Li L; Chen YL; Qiu YX; Li YC
    Front Cardiovasc Med; 2022; 9():1011037. PubMed ID: 36407450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WATCHMAN versus ACP or Amulet devices for left atrial appendage occlusion: a sub-analysis of the multicentre LAARGE registry.
    Ledwoch J; Franke J; Akin I; Geist V; Weiß C; Zeymer U; Pleger S; Hochadel M; Mudra H; Senges J; Lewalter T; Brachmann J; Sievert H
    EuroIntervention; 2020 Dec; 16(11):e942-e949. PubMed ID: 32451320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
    Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
    Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.